News

Exclusive: Merck, rivals eye Inhibrx experimental cancer drug tied to Keytruda, sources say - Reuters

admin April 22, 2026 View Original Source
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPbmV4NWgtNHIxcFNOYk8tdEdrZVQ2cmdKQUJsWG12bUszbXVLN3NJZWo1VnowM0NocTVPb3RtQ2dSWE5JeXJiRnF4RkR4LVlGcEtrZHRTWUxnS3UyajM3QUlUbDVhZ0pqZWdCSE5QRS1QTE9BekIyTlF2OFZqZFF0SHZCaHZVTHZ3amRfd3VUdGZUSUlsQm9jZDg5M3FHaDBDdGFkc1hFM0t3U1N6SkxvamppdUMyVmFicHA0VDZDSQ?oc=5" target="_blank">Exclusive: Merck, rivals eye Inhibrx experimental cancer drug tied to Keytruda, sources say</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>
Exclusive: Merck, rivals eye Inhibrx experimental cancer drug tied to Keytruda, sources say  Reuters

This article was originally published at: https://news.google.com/rss/articles/CBMivwFBVV95cUxPbmV4...